冷泉港亞洲2013會議：腫瘤免疫及免疫療法
Tumor Immunology and Immunotherapy
腫瘤免疫及免疫療法
2013年10月28 – 11月1日 | 蘇州. 獨墅湖會議酒店
http://www.csh-asia.org/13Immune.html
科學組委會成員:
Xuetao Cao, Chinese Academy of Medical Sciences, China
Xin-Yuan Fu, National University of Singapore, Singapore
Olivera Finn, University of Pittsburgh School of Medicine, USA
Cornelius Melief, Leiden University Medical Center, The Netherlands
會議主題：
1. Cancer vaccines
2. Antibody therapy
3. Adoptive T cell therapy
4. Combination of immunotherapy with other therapies
5. Cancer, inflammation and immunosuppression
6. Immune escape of cancer
7. Aging, immunity and cancer
8. Oncogenic viruses, immunity and immunotherapy
主題演講嘉賓:
David Baltimore, California Institute of Technology, USA
Engineering Immunologic Protection and Therapy
Xiaodong Wang, National Institute of Biological Sciences, China
TNFalpha and TLR3/4 induced necrosis pathway
特邀演講嘉賓:
Jean Pierre Abastado, Singapore Immunology Network, Singapore
Cancer cells hijack immune cells for dissemination and metastasis.
Jannie Borst, The Netherlands Cancer Institute, The Netherlands
Mechanistic insights in T-cell costimulation by the CD27/CD70 pathway encourage application in cancer immunotherapy
Jay Berzofsky, National Cancer Institute, USA
Cancer Vaccines: Basic strategies and clinical translation
Vincenzo Bronte, University of Verona, Italy
Molecular and metabolic control of adaptive immunity by tumor-induced myelopoiesis
Xuetao Cao, Chinese Academy of Medical Sciences, China
New cell subsets in tumor immune escape and metastasis
Yuan Chang, University of Pittsburgh Cancer Institute, USA
Merkel cell polyomavirus: a model in tumorigenesis and immunity
Lieping Chen, Yale School of Medicine, USA
Inhibiting co-inhibitors for immunotherapy of cancer
Olivera Finn, University of Pittsburgh School of Medicine, USA
Disease associated antigens as targets for cancer immunosurvellance and candidates for prophylactic cancer vaccines
Xin-Yuan Fu, National University of Singapore, Singapore
An Inducible Cancer Metastatic Niche Mediated by Endothelial STAT3
Yang-Xin Fu, The University of Chicago, USA
Changing tumor microenvironment by local ablative radiation and modified antibody for better immunotherapy
Yukai He, Georgia Regents University Cancer Center, USA
Engineering epitope-optimized AFP-based gene vaccines to prevent autochthonous hepatocellular carcinoma
Erica Jensen Jarolim, Medical University Vienna, Austria
Comparative oncology: Development of xenogenic vaccines and recombinant antibodies for dog mammary cancer patients.
Dieter Kabelitz, University of Kiel, Germany
Towards improving immunotherapeutic strategies with human gamma/delta T-cells
Yutaka Kawakami, Keio University School of Medicine, Japan
Different tumor immunoenvironments among patients and their modification by molecular targeted therapy
Binfeng Lu, University of Pittsburgh School of Medicine, USA
Danger signal IL-33 and antitumor Immunity
Ignacio Melero, University of Navarra, Spain
unfolding CD137-based cancer immunotherapy
Cornelius Melief, Leiden University Medical Center, The Netherlands
TLR-ligand peptide conjugates for superior therapeutic vaccination against immunogenic cancers
Ira Mellman, Genentech, USA
Oncology meets immunology: targeting PD-L1 in combination
Andrew Mellor, Georgia Regents University, USA
A Tale with a STING: Pivotal pathways that control immune responses to DNA
Graham Pawelec, University of Tuebingen Center for Medical Research, Germany
Immunosenescence and cancer
Zhihai Qin ,Chinese Academy of Sciences, China
S100A4(FSP-1)promotes liver fibrosis and hepatocellular carcinoma
Michel Sadelain, Memorial Sloan-Kettering Cancer Center, USA
Targeting tumors with genetically enhanced T lymphocytes
Mark Smyth, Queensland Institute of Medical Research in Brisbane, Australia
Receptor ligand interactions that regulate tumor growth and metastases
Cassian Yee, UT MD Anderson Cancer Center, USA
Adoptive T Cell Therapy of Cancer: Age of Renaissance
Hua Yu, City of Hope Duarte, USA
Pathways to Targeting STAT3: Transition into the Clinic
Rong-Fu Wang, The Methodist Hospital Research Institute Houston, USA
Innate signaling and antigen-specific cancer immunotherapy
Limin Zheng, Sun Yat-sen University, China
Macrophage Plasticity in Distinct Microenvironments of Human Tumors
Weiping Zou, University of Michigan Medical School, USA
Immune elements shape cancer stemness
|
|
聯系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029 Fax: +86-512-62729028 Email: mikeji@cshl.edu Website: www.csh-asia.org |
相關鏈接： 2013年冷泉港亞洲（CSH Asia）會議搶先預覽！
- 因美納邀您參加CSCO第九屆血液腫瘤學術大會
- 千奧星科精彩亮相2025神經科學技術研討會
- 諾達思攜多款產品亮相2025中國人類工效學學術會議
- 美森與您相約CMC-CHINA第七屆中國制藥工業博覽會
- CPHI&PMEC 2025制藥工業展（深圳）通知
- 2026第三十三屆成都醫療健康博覽會邀請函
- NGDx2025中國先進診斷技術開發與應用論壇議程表
- 關于征集藥食同源及藥膳配方食品標準試點單位的通知
- 關于征集藥食同源優選產品評價規范參編單位的通知
- QD中國攜單細胞方案亮相國際干細胞研究學會年會
- 維拓啟創助力2025表面肌電論壇在杭成功召開
- 易科泰應邀參加動物遺傳專業委員會2025年學術年會
- 奧偉登攜前沿顯微技術亮相廈門2025中國材料大會
- CIIDC 2025中國（成都）儀器創新發展大會通知
- 2025新疆（昌吉）農業展覽會即將震撼啟幕
- 美森與您相約CMC-CHINA第七屆中國制藥工業博覽會
- 美森攜CTCC細胞庫與干細胞技術亮相東南大學高研院
- 尚恩生物暑期特惠：胞折扣30%，三大套餐1180元起！
- 尚恩生物推出原代細胞熱銷款限時特惠活動！
- 賽業生物直播預告：細胞培養的難點與解決方案
- 尚恩生物五一福利局，配套試劑一步到位！
- 細胞檢測試劑盒免費送，反饋即享100%京東卡好禮！
- 2025動物生物育種與繁殖技術學術交流研討會通知
- 開年上新：尚恩生物細胞轉染服務正式上線啦!
- 尚恩生物開年大促銷，福利疊滿解鎖新學期！
- 尚恩生物年終大促—4款細胞系套餐送500ml完全培養基
- 尚恩生物雙11促銷：任意細胞系+配套完培下單立減100
- 賽業今晚直播：點突變細胞株構建策略及其研究應用
- 賽業講座：兩步灌流法提取原代鼠肝臟Kupffer細胞
- 賽業生物課程預告：基因編輯細胞技術及其研究應用
Copyright(C) 1998-2025 生物器材網 電話：021-64166852;13621656896 E-mail：info@bio-equip.com